Class information for:
Level 1: FORMOTEROL//SALMETEROL//BUDESONIDE FORMOTEROL

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
3180 1966 37.3 73%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
93 25323 ASTHMA//AIRWAY SMOOTH MUSCLE//EOSINOPHILS

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 FORMOTEROL Author keyword 194 54% 13% 252
2 SALMETEROL Author keyword 168 47% 13% 264
3 BUDESONIDE FORMOTEROL Author keyword 52 70% 2% 43
4 LEVALBUTEROL Author keyword 35 67% 2% 31
5 S ALBUTEROL Author keyword 24 91% 1% 10
6 LONG ACTING BETA AGONISTS Author keyword 22 49% 2% 32
7 SALMETEROL FLUTICASONE Author keyword 19 70% 1% 16
8 RACEMIC ALBUTEROL Author keyword 17 79% 1% 11
9 SYMBICORT Author keyword 15 82% 0% 9
10 SALBUTAMOL Author keyword 15 12% 6% 112

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 FORMOTEROL 194 54% 13% 252 Search FORMOTEROL Search FORMOTEROL
2 SALMETEROL 168 47% 13% 264 Search SALMETEROL Search SALMETEROL
3 BUDESONIDE FORMOTEROL 52 70% 2% 43 Search BUDESONIDE+FORMOTEROL Search BUDESONIDE+FORMOTEROL
4 LEVALBUTEROL 35 67% 2% 31 Search LEVALBUTEROL Search LEVALBUTEROL
5 S ALBUTEROL 24 91% 1% 10 Search S+ALBUTEROL Search S+ALBUTEROL
6 LONG ACTING BETA AGONISTS 22 49% 2% 32 Search LONG+ACTING+BETA+AGONISTS Search LONG+ACTING+BETA+AGONISTS
7 SALMETEROL FLUTICASONE 19 70% 1% 16 Search SALMETEROL+FLUTICASONE Search SALMETEROL+FLUTICASONE
8 RACEMIC ALBUTEROL 17 79% 1% 11 Search RACEMIC+ALBUTEROL Search RACEMIC+ALBUTEROL
9 SYMBICORT 15 82% 0% 9 Search SYMBICORT Search SYMBICORT
10 SALBUTAMOL 15 12% 6% 112 Search SALBUTAMOL Search SALBUTAMOL

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 SINGLE INHALER 271 82% 8% 157
2 FORMOTEROL 186 46% 15% 302
3 SALMETEROL 171 29% 26% 502
4 INHALED FORMOTEROL 146 82% 4% 84
5 SALBUTAMOL 104 23% 20% 398
6 BUDESONIDE FORMOTEROL MAINTENANCE 76 93% 1% 28
7 PRESCRIBED FENOTEROL 60 49% 4% 88
8 RELIEVER THERAPY 54 74% 2% 40
9 S ALBUTEROL 50 84% 1% 27
10 BETA 2 ADRENOCEPTOR AGONIST 49 56% 3% 60

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Meta-analysis: Effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths 2006 253 79 72%
Safety of long-acting beta agonists for the treatment of asthma: clearing the air 2012 23 39 92%
Long-Acting beta(2)-Agonist Step-off in Patients With Controlled Asthma Systematic Review With Meta-analysis 2012 21 39 90%
Meta-analysis: Effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events 2008 59 71 79%
Scientific rationale for inhaled combination therapy with long-acting beta(2)-agonists and corticosteroids 2002 217 91 60%
Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma 2015 1 34 65%
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children 2010 37 243 79%
Scientific rationale for using a single inhaler for asthma control 2007 66 73 71%
Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review 2009 33 86 90%
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events 2013 8 127 87%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 AIRWAY DIS HEART LUNG 2 67% 0.1% 2
2 TEAM PHARMACOEPIDEMIOL PHARMACOECON 2 67% 0.1% 2
3 BARLICKI UNIV HOSP 2 18% 0.5% 9
4 CLIN UNIT CHILDHOOD ASTHMA 2 43% 0.2% 3
5 ABT PNEUMOL IMMUNOL 1 100% 0.1% 2
6 PULM ALLERGY ASSOC 1 100% 0.1% 2
7 GOTEBORG UNIV 1 33% 0.2% 3
8 ASTHMA ALLERGY AIRWAY 1 30% 0.2% 3
9 MED EVALUAT UNIT 1 11% 0.5% 9
10 LUNG PATHOPHYSIOL 1 40% 0.1% 2

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000169211 CICLESONIDE//INHALED CORTICOSTEROIDS//FLUTICASONE PROPIONATE
2 0.0000133718 TIOTROPIUM//INDACATEROL//LONG ACTING MUSCARINIC ANTAGONIST
3 0.0000114147 PROPRANOLOL INDUCED BRONCHOCONSTRICTION//MED FELS CANC MOL BIOL//ALLERGIC BRONCHOCONSTRICTION
4 0.0000109249 ADRB2//BETA2 ADRENERGIC RECEPTOR//BETA 2 ADRENERGIC RECEPTOR GENE
5 0.0000101450 BAMBUTEROL//NOCTURNAL ASTHMA//JAMES B SKATRUD PULM SLEEP
6 0.0000098899 STATUS ASTHMATICUS//ACUTE ASTHMA//ACUTE SEVERE ASTHMA
7 0.0000095628 JOURNAL OF ASTHMA//ASTHMA CONTROL//ASTHMA EDUCATION
8 0.0000076601 JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG//NEBULIZER//METERED DOSE INHALER
9 0.0000064593 INDUCED SPUTUM//SPUTUM CELL COUNTS//SEVERE ASTHMA
10 0.0000063113 EXERCISE INDUCED ASTHMA//EXERCISE INDUCED BRONCHOCONSTRICTION//EXERCISE INDUCED BRONCHOSPASM